Patents by Inventor Anjan Dasgupta

Anjan Dasgupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • One step nanosensor for single and multidrug resistance in acute coronary syndrome (ACS)
    Patent number: 8546092
    Abstract: An embodiment relates to a method of detecting a drug resistance in a patient comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Another embodiment relates to a method of monitoring a thrombotic risk factor in a subject in a general population comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Yet another embodiment relates to a kit comprising nanoparticles, a fluorescence dye tagged antibody and optionally a buffer, wherein the kit is configured to detect a drug resistance in a patient or a likelihood of the thrombotic risk factor in a subject in general population.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: October 1, 2013
    Assignee: University of Calcutta
    Inventors: Suryyani Deb, Anjan Dasgupta, Prabir Lahiri
  • ONE STEP NANOSENSOR FOR SINGLE AND MULTIDRUG RESISTANCE IN ACUTE CORONARY SYNDROME (ACS)
    Publication number: 20110053172
    Abstract: An embodiment relates to a method of detecting a drug resistance in a patient comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Another embodiment relates to a method of monitoring a thrombotic risk factor in a subject in a general population comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Yet another embodiment relates to a kit comprising nanoparticles, a fluorescence dye tagged antibody and optionally a buffer, wherein the kit is configured to detect a drug resistance in a patient or a likelihood of the thrombotic risk factor in a subject in general population.
    Type: Application
    Filed: December 7, 2009
    Publication date: March 3, 2011
    Applicant: UNIVERSITY OF CALCUTTA
    Inventors: Suryyani Deb, Anjan Dasgupta, Prabir Lahiri